「by」の検索結果
75件：11～15件目を表示
-
Publications | Research & Development | SENJU Pharmaceutica
apy. 2024 Oct;13(10):2629-2644. Identification of meibomian gland testosterone metabolites produced by tissue-intrinsic intracrine deactivation activity Khanh Tien Nguyen Pham 1, Takahito Miyake 1, To...
http://www.senju.co.jp/english/rd/thesis/ -
ical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the launch of distribution of software for dry-eye analysis in Japan as an option of RE...
https://www.senju.co.jp/system/files/content_news/2024-09/ENG_20240906_0.pdf -
that it has received approval for the marketing of “Mytear Lumify” (OTC drug requiring instruction by pharmacist, hereinafter this "Product") from Ministry of Health, Labour and Welfare. Th...
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903.pdf -
Mytear HARD LENS WETTING SOLUTION | OTC Products, etc. | Products | SENJU Pharmaceutical
persons should consult a physician or pharmacist before using this product: Persons under treatment by a physician Persons who or whose family members have allergies Persons who have had allergies to ...
http://www.senju.co.jp/english/products/wettingsolution.html -
Management Policy | About Senju | SENJU Pharmaceutical
vision, and ideal employee image) into a concept called the "Senju Sense" that is shared by all Senju employees in the organization. To enhance unity and understanding among our employees, ...
http://www.senju.co.jp/english/about/philosophy.html